Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Request a free trial

No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: CIPRO

« Back to Dashboard
Cipro is a drug marketed by Bayer Hlthcare, Alcon Pharms Ltd, Bayer Pharms, Lupin Ltd, Bedford Labs, Claris Pharmaservice, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira, Teva Pharms Usa, Actavis Labs Fl Inc, Anchen Pharms, Dr Reddys Labs Ltd, Mylan Pharms Inc, Sandoz, Akorn Inc, Apotex Inc, Fdc Ltd, Igi Labs Inc, Nexus Pharms, Pharmaforce, Watson Labs Inc, Apotex, Aurobindo Pharma, Barr, Carlsbad, Hikma, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Sun Pharm Inds Ltd, Taro, Teva, Unique Pharm Labs, Watson Labs, Acs Dobfar Info Sa, Baxter Hlthcare, Bedford, and Teva Pharms. and is included in fifty-five NDAs. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in CIPRO is ciprofloxacin; dexamethasone. There are thirty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.

Summary for Tradename: CIPRO

Patents:8
Applicants:40
NDAs:55
Suppliers / Packagers: see list4

Pharmacology for Tradename: CIPRO

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

Clinical Trials for: CIPRO

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
Status: Completed Condition: Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; Otitis

Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
Status: Completed Condition: Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; Otitis

Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
Status: Completed Condition: Cystic Fibrosis

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension
Status: Completed Condition: Otitis Externa

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis
Status: Completed Condition: Bronchiectasis

Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin
Status: Completed Condition: Healthy

Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens
Status: Completed Condition: Urinary Tract Infections

Impact of Formulation on Ciprofloxacin Oral Absorption
Status: Completed Condition: Healthy

A Phase IV Study of Cipro XR in Uncomplicated UTI
Status: Completed Condition: Urinary Tract Infections

Ciprofloxacin for Prevention of BK Infection
Status: Recruiting Condition: BK Virus Infection

Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Status: Completed Condition: Urinary Tract Infection

Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases
Status: Completed Condition: Respiratory System

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed Condition: Disease, Pulmonary

Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections
Status: Completed Condition: Urinary Tract Infection

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12
Status: Completed Condition: Pseudomonas Infection

Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth
Status: Enrolling by invitation Condition: Small Intestinal Bacterial Overgrowth

Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine
Status: Completed Condition: Healthy

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy
Status: Not yet recruiting Condition: Prostate Cancer

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
Status: Completed Condition: Healthy

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg
Status: Completed Condition: Healthy

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg
Status: Completed Condition: Healthy

Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease
Status: Completed Condition: Crohn's Disease

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed Condition: Pulmonary Disease, Chronic Obstructive

Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Status: Recruiting Condition: Bronchiectasis

Comparison of Infection and Urosepsis Rates During Retrograde Intrarenal Surgery After Multiple-, Single-, Zero-dose of Ciprofloxacin Prophylaxis
Status: Recruiting Condition: Kidney Stones

Study of Antibiotics in the Treatment of Colonic Crohn's Disease
Status: Terminated Condition: Crohn's Disease

Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis
Status: Not yet recruiting Condition: Alcoholic Hepatitis; Alcoholic Cirrhosis

Ciprofloxacin on Burned Patients
Status: Completed Condition: Burns; Bacterial Infections

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder
Status: Completed Condition: Infection; Pulmonary Disease, Chronic Obstructive

Ciprofloxacin BioThrax Co-Administration Study
Status: Completed Condition: Anthrax

Ph1 Study of Valortim and Ciprofloxacin in Humans
Status: Suspended Condition: Anthrax

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Status: Active, not recruiting Condition: Bronchiectasis

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
Status: Terminated Condition: Bladder Cancer

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's
Status: Completed Condition: Crohn's Disease With Perianal Fistulas

Ciprofloxacin Multiple Dose for Adult Cholera
Status: Completed Condition: Cholera

An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor
Status: Completed Condition: Cystic Fibrosis

Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention
Status: Recruiting Condition: Adverse Reaction to Other Drugs and Medicines

Cefpodoxime vs Ciprofloxacin for Acute Cystitis
Status: Completed Condition: Urinary Tract Infection

Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
Status: Terminated Condition: Inflammation; Bacterial Infections

Population Pharmacokinetics of Anti-infectious Drugs in Children
Status: Completed Condition: Pediatrics; Ceftazidime; Ciprofloxacin; Voriconazole

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
Status: Completed Condition: Urinary Tract Infection

Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"
Status: Completed Condition: Non-Cystic Fibrosis Bronchiectasis

Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
Status: Completed Condition: Healthy Volunteers; Non-smokers

TINN Pharmacokinetics (PK) Study Treat Infections iN Neonates
Status: Recruiting Condition: Pharmacokinetics of Ciprofloxacin in Neonates

BAY 0 9867 Cipro Pediatric Use Study (QUIP)
Status: Completed Condition: Infectious Diseases

Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy
Status: Active, not recruiting Condition: Urinary Tract Infections

Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis
Status: Completed Condition: Chronic Periodontitis

To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)
Status: Completed Condition: Pulmonary Disease, Chronic Obstructive

A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans
Status: Recruiting Condition: Plague

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)
Status: Terminated Condition: Elevated Prostate Specific Antigen

Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and PK of ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers
Status: Completed Condition: Inhalational Anthrax

Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
Status: Completed Condition: Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive

Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)
Status: Completed Condition: Urinary Tract Infections

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions
Status: Completed Condition: Fasting

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions
Status: Completed Condition: Fed

REaCT Integrated Consent Model to Compare Two Standard of Care Regimens
Status: Recruiting Condition: Breast Cancer

A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
Status: Completed Condition: Cystic Fibrosis

A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults
Status: Terminated Condition: Diverticular Sigmoïditis

Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers
Status: Completed Condition: Acute Bacterial Corneal Ulcers; Bacterial Keratitis

Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial
Status: Completed Condition: Cholera

Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes
Status: Terminated Condition: Otitis Media in Patients With Tympanostomy Tubes.

Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora
Status: Terminated Condition: Healthy Volunteers

Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution
Status: Completed Condition: Infection

Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle
Status: Completed Condition: Ulcerative Colitis

Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis
Status: Completed Condition: Cystic Fibrosis

BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
Status: Recruiting Condition: HIV; Salivary Gland Disease; Benign Lymphoepithelial Lesion

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
Status: Completed Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Status: Completed Condition: Infection; Multiple Myeloma

Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics
Status: Recruiting Condition: Bacterial Resistance

Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis
Status: Recruiting Condition: Non Cystic Fibrosis Bronchiectasis

Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag
Status: Completed Condition: Healthy Subjects; Purpura, Thrombocytopenic, Idiopathic

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy
Status: Recruiting Condition: Benign Prostate Hyperplasia

A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Status: Terminated Condition: Otitis Externa

Comparative Efficacy and Safety of Two Ciprofloxacin 0.3% and Dexamethasone 0.1% Formulations in Subjects With Acute Otitis Externa
Status: Recruiting Condition: Acute Otitis Externa

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
Status: Terminated Condition: Chronic Myeloproliferative Disorders; Fever, Sweats, and Hot Flashes; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neutropenia; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific

Antibiotics and Hydroxychloroquine in Crohn's
Status: Recruiting Condition: Crohn's Disease

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Status: Recruiting Condition: Febrile Neutropenia

Short-course Methenamine Hippurate for Prevention of Post-operative UTI
Status: Recruiting Condition: Urinary Tract Infections; Catheter-Related Infections

Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Status: Recruiting Condition: Prostate Cancer; Urinary Tract Infection; Clostridium Difficile

Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Status: Recruiting Condition: Traveler's Diarrhea

Antibiotic Prophylaxis in Laparoscopic Cholecystectomy
Status: Recruiting Condition: Cholelithiasis

A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration
Status: Recruiting Condition: Pancreatic Cysts

Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Status: Recruiting Condition: SBP; Liver Cirrhosis

Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis
Status: Completed Condition: Urinary Tract Infections

Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Status: Recruiting Condition: Infection

BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Status: Completed Condition: Bacterial Infections

Meropenem and Ciprofloxacin Dosing in Septic Shock
Status: Not yet recruiting Condition: Septic Shock

Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
Status: Completed Condition: Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; Otitis

Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Status: Active, not recruiting Condition: Urinary Tract Infections; Acute Pyelonephritis

Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients
Status: Withdrawn Condition: Cirrhosis; Ascites; Infections

Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
Status: Completed Condition: Pulmonary Diseases

A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia
Status: Completed Condition: Pneumonia

A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis
Status: Completed Condition: Prostatitis

TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light
Status: Completed Condition: Hepatitis C Virus

Trimethoprim-Sulfamethoxazole Versus Ciprofloxacin in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation
Status: Completed Condition: Chronic Obstructive Pulmonary Disease; Sepsis; Antibiotics

Targeted Retreatment of COPD Exacerbations
Status: Recruiting Condition: Chronic Obstructive Pulmonary Disease (COPD)

Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI)
Status: Enrolling by invitation Condition: Urolithiasis

Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers
Status: Terminated Condition: Diabetic Foot Ulcers

An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment
Status: Completed Condition: Retinal Detachment

Longitudinal Study of the Human Intestinal Microbiome
Status: Completed Condition: Intestinal Microbiome

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076089-002Jun 9, 2004RXNo<disabled><disabled>
Taro
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076912-003Oct 6, 2004RXNo<disabled><disabled>
Dr Reddys Labs Ltd
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL077701-002Oct 31, 2007DISCNNo<disabled><disabled>
Hikma Farmaceutica
CIPROFLOXACIN
ciprofloxacin
INJECTABLE;INJECTION076717-002Dec 22, 2009RXNo<disabled><disabled>
Pliva
CIPROFLOXACIN HYDROCHLORIDE
ciprofloxacin hydrochloride
TABLET;ORAL076426-002Jun 15, 2005DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: CIPRO

Drugname Dosage Strength RLD Submissiondate
ciprofloxacinOral Suspension250 mg/5 mL and 500 mg/ 5 mLCipro10/16/2009
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc